Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
524

Summary

Conditions
  • Biliary Tract Cancer
  • Cholangiocarcinoma
  • Gallbladder Cancer
Type
Interventional
Phase
Phase 2Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04066491
Collaborators
Merck KGaA, Darmstadt, Germany
Investigators
Study Director: Medical Responsible Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany